Change of Largest Shareholder Due to Rehabilitation Plan Causes Massive Dilution - Concerns of Plummeting Value for Existing Shareholders


  • Following court approval of the rehabilitation plan, a third-party allotment, debt-to-equity swap, and stock consolidation led to a change in the largest shareholder from Lim Kyung-sook and 9 others (2.54% stake) to Haemily Co., Ltd. (48.77% stake).
  • The new largest shareholder, Haemily, is a health supplement and food manufacturer, whose own largest shareholder Hwang Sung-joo holds 62.48% of Haemily.
  • The change involved issuing 110,000,000 new common shares after consolidation and conversion, severely diluting existing shareholders.
  • Key dates: rehabilitation commencement (2025-09-16), plan approval (2026-03-20), capital reduction and paid-in capital increase decisions (2026-03-23), and execution (2026-04-09).
  • [AI Summary]The change in largest shareholder due to the rehabilitation plan results in extreme dilution for existing shareholders, likely causing a sharp short-term stock price decline. However, the rehabilitation process gives the company a chance to survive as a going concern, offering some recovery potential, though investment value is significantly impaired.

KOSDAQ Filing Information


  • Filing: [Correction of Description] Change of Largest Shareholder
  • Company: Eone Diagnomics Genome Center (245620)
  • Submission: Eone Diagnomics Genome Center Co., Ltd.
  • Receipt: 04-15-2026
  • Under KRX KOSDAQ Market Division